614 filings
Page 3 of 31
D
g89t pf5glkhgwc5fnjx
7 Jul 23
Exempt offering of security
4:11pm
8-K
7zb1r ihij4w0jx
30 Jun 23
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
4:21pm
424B5
qmauv8x4ek2l 5vcmchn
30 Jun 23
Prospectus supplement for primary offering
8:42am
424B3
2m9npyv9s7
30 Jun 23
Prospectus supplement
8:41am
8-K
z2aj4mijbok3cxoxv05
14 Jun 23
NeuBase Announces 1-for-20 Reverse Stock Split
4:10pm
10-QT
3ar o1mewwgrs4v
5 Jun 23
Quarterly report for transitional period
4:05pm
8-K
4nzapr
22 May 23
Regulation FD Disclosure
7:00am
8-K
1gba0ql4
18 May 23
Departure of Directors or Certain Officers
4:05pm
8-K
4nkvd54ij rf2jwz8
11 May 23
NeuBase Reports Business Update and Financial Results for the First Quarter of 2023
4:20pm
8-K
skgn0 whu
24 Apr 23
Amendments to Articles of Incorporation or Bylaws
4:05pm
8-K
kj8gs
29 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:04pm
UPLOAD
30vlkuw
20 Mar 23
Letter from SEC
12:00am
4
99g2 r6tc4502t
17 Mar 23
NeuBase Therapeutics / Todd P. Branning ownership change
4:11pm
4
jmhw4tn6 pnxcty4j7
17 Mar 23
NeuBase Therapeutics / Dietrich A Stephan ownership change
4:11pm
CORRESP
7fomqo 9vmyhd633z8au
16 Mar 23
Correspondence with SEC
12:00am
UPLOAD
gxokr
8 Mar 23
Letter from SEC
12:00am
S-8
h4y66cvk8tu ad
6 Mar 23
Registration of securities for employees
4:22pm
4
s0v51a
15 Feb 23
NeuBase Therapeutics / Dietrich A Stephan ownership change
7:30pm
8-K
jnd1s2
14 Feb 23
NeuBase Therapeutics Reports Business Update and Financial Results
4:20pm